Bench to Boardroom Workshops 2012
There will be a total of 8 workshops - each accommodating up to 20 delegates. The workshops will cover technological, technical and commercial issues, with the aim of educating and informing. The plan is that as a result of attending, delegates will have increased their knowledge of how to do business faster and more economically, whilst retaining quality at all times.
To register your interest in attending a workshop you will need to sign up for a Full Event Pass which can be done by clicking here. Once you have purchased your Full Event Pass please select the corresponding ‘click here’ link in the table below.
|
Time
|
Title
|
Host
|
Reserve
|
|
10:45
|
Learn how the TSB, in partnership with the Health KTN, has successfully supported Life Science companies and about the opportunities for you
|
Dr Terry O'Neill Knowledge Transfer Manager, HealthTech & Medicines KTN
|
Click here
|
| 10:45 |
Drug to Drug Interactions – And How To Avoid Them |
Guy Webber
Chief Scientist, Quotient Bioresearch Ltd
|
Click here |
| 10:45 |
Implementing new technologies in the NHS: genome sequencing |
Dr Anna Pokorska-Bocci
Programme Lead, PHG Foundation |
Click here |
| 10:45 |
What matters in cell culture?
Click here to read an abstract.
|
Thomas Stelzer, Cell Culture Commercial Manager, Thermo Fisher Scientific |
Click here |
| |
| 14:15 |
The NHS - Virgin Territory?
|
Greer Deal
Global Regulatory Services |
Click here |
| 14:15 |
Starting a New Venture: People, Places and Planning for Success
Click here to read an abstract
|
Dr Katy Evans-Roberts Babraham Research Campus
Dr Belinda Clarke ideaSpace Enterprise Accelerator |
Click here |
| 14.15 |
How current pre-clinical ADME Tox Studies are Improving Clinical Outcomes in Drug Discovery
|
Dr Anthony D Baxter, CEO, Cyprotex PLC |
Click here |
| 14.15 |
Licensing & Patent Box |
Tom Byng and Debbie Toms, Deloitte |
Click here |